Regenxbio (NASDAQ:RGNX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.

Open	$11.02
Close	$10.75
Volume / Avg.	507.89K / 519.62K
Day Range	10.72 - 11.07
52 Wk Range	10.98 - 28.80
Market Cap	$529.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	12.13%
Days to Cover	9.41

Recent News

Why Is Clearside Biomedical Stock Gaining Today?

Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS Microinjector and strategic partnerships.

Vandana Singh

FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy

The FDA has approved Sarepta Therapeutics' Elevidys for treating Duchenne muscular dystrophy in patients aged 4 and older with specific DMD gene mutations.

Vandana Singh

Urogen Pharma Surges 9.7%: Is This an Indication of Further Gains?

Urogen Pharma (NASDAQ: URGN) shares soared 9.7% in the last trading session to close at $19.20. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 32.5% gain over the past four weeks.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Regenxbio Inc

Sector

Health Care

Industry

Biotechnology

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regenxbio (RGNX) stock?

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Who are Regenxbio (RGNX) competitors?

Other companies in Regenxbio’s space includes: Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL) and Altimmune (NASDAQ:ALT).

What is the target price for Regenxbio (RGNX) stock?

There is no analysis for Regenxbio.

What is the forecast for Regenxbio (RGNX) stock?

Regenxbio has a consensus price target of $41.13.

Current stock price for Regenxbio (RGNX)?

The stock price for Regenxbio (NASDAQ: RGNX) is $10.75 last updated July 2, 2024 at 4:00 PM EDT.

Does Regenxbio (RGNX) pay a dividend?

There are no upcoming dividends for Regenxbio.

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

Regenxbio’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is Regenxbio (RGNX) going to split?

There is no upcoming split for Regenxbio.

What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Regenxbio

Regenxbio (RGNX) Forecast